Webinar Date/Time: Wednesday, March 6th, 2024 at 11am EST | 8am PST | 4pm GMT | 5pm CET
As investment in digital and omnichannel engagement continues to grow, personal interactions remain core to the success of most treatments. While most life sciences companies have similar visions around personalized engagement, legacy ecosystems and corporate focus have led to different approaches and inconsistent results. In this webinar, you will have the opportunity to learn how some of your peers are pushing forward innovative, human-centric design approaches and AI to reimagine engagement solutions and achieve better outcomes.
Register Free: https://www.pharmexec.com/pe/optimize-outcomes
Event Overview:
Healthcare providers (HCP) see value in personal interaction when it comes to their relationship with a given life sciences company. Research shows that the dominant factor enabling successful brand launches in the United States is increased in-person interactions. 88% of HCPs would be twice as likely to meet with other companies/reps if they could replicate the attributes of their existing successful relationships with life sciences companies.
Accelerating rep engagement via hyper-personalized decision intelligence, superior UI/UX, and omnichannel-orchestrated workflows leads to better outcomes. This requires reimagining what a next-generation customer relationship management (CRM) system should consist of, including a more human-centric design, integrated solutions open for innovation and collaboration, and targeted AI/ML use.
Three key take-aways
Speakers:
Aleksandra Ilic
VP, Customer Engagement Solutions, FFO
IQVIA
Aleksandra has more than 20 years of experience working with life sciences companies, focusing on solutions and services that optimize customer journeys. In her current role, she develops business solutions for commercial business and technical problems, and additionally brings to market new value propositions. This includes next-generation engagement solutions, AI/ML-driven actionable intelligence, omnichannel orchestration, and supporting clients’ HCP-, thought leader-, and patient-centric initiatives.
António Pregueiro
VP New Offerings, Field Force Operations
IQVIA
With almost two decades of experience within pharma and biotech, consulting and industry, Dr. Pregueiro has worked across many aspects of life sciences. He has led multiple transformation programs, integrating new business models with people and culture development, and more recently specialized in developing digital launch strategies for specialty pharma brands and new-in-class therapeutics. At IQVIA, he has developed several new offerings involving advanced analytics and AI/ML, including Generative AI.
Register Free: https://www.pharmexec.com/pe/optimize-outcomes
Cell and Gene Therapy Check-in 2024
January 18th 2024Fran Gregory, VP of Emerging Therapies, Cardinal Health discusses her career, how both CAR-T therapies and personalization have been gaining momentum and what kind of progress we expect to see from them, some of the biggest hurdles facing their section of the industry, the importance of patient advocacy and so much more.
Plan Ahead: Mastering Your AI Budget for 2025 Success
October 9th 2024Generative AI is just one part of the artificial intelligence and machine learning that is being used by life science organizations, emerging as a major area of interest and an area in which costs and ROI are still largely unknown.